Predictions
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.22
11.06.21
11.06.21
€4.00
11.06.22
11.06.22
-69.57%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€18.77
11.06.21
11.06.21
€23.20
11.06.22
11.06.22
-14.32%
24.06.21
24.06.21
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Galapagos N.V.
Start price
Target price
Perf. (%)
€65.08
09.06.21
09.06.21
€70.00
09.06.22
09.06.22
-30.73%
13.10.21
13.10.21
Could be worthwhile Investment >10% per year
Invitae Corp
Start price
Target price
Perf. (%)
€25.10
09.06.21
09.06.21
€30.00
09.06.22
09.06.22
-89.88%
10.06.22
10.06.22
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€320.85
08.06.21
08.06.21
€330.00
08.06.22
08.06.22
-41.88%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Top 10 in its market
Well known brand
Hologic Inc.
Start price
Target price
Perf. (%)
€49.93
07.06.21
07.06.21
€55.00
07.06.22
07.06.22
42.14%
08.06.22
08.06.22
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€238.80
07.06.21
07.06.21
€250.00
29.04.22
29.04.22
15.03%
30.04.22
30.04.22
Could be worthwhile Investment >10% per year
Diasorin SpA
Start price
Target price
Perf. (%)
€142.25
06.06.21
06.06.21
-
06.06.22
06.06.22
-15.04%
07.06.22
07.06.22
Could be worthwhile Investment >10% per year
AstraZeneca plc
Start price
Target price
Perf. (%)
€91.61
03.06.21
03.06.21
€115.00
03.06.22
03.06.22
34.21%
04.06.22
04.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.30
02.06.21
02.06.21
-
02.06.22
02.06.22
9.09%
20.06.21
20.06.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
M1 Kliniken AG
Start price
Target price
Perf. (%)
€10.35
31.05.21
31.05.21
-
31.05.24
31.05.24
40.10%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Haemato AG
Start price
Target price
Perf. (%)
€29.20
31.05.21
31.05.21
-
31.05.24
31.05.24
-36.99%
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.74
31.05.21
31.05.21
€15.00
31.05.22
31.05.22
-60.61%
01.06.22
01.06.22
Fair valuation
Strong uniques
Leading role in innovation
Bad rating
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.18
31.05.21
31.05.21
€4.00
31.05.22
31.05.22
4.59%
14.06.21
14.06.21
Could be worthwhile Investment >10% per year
Ziopharm Oncology
Start price
Target price
Perf. (%)
€2.44
31.05.21
31.05.21
€4.00
31.05.22
31.05.22
-2.46%
07.06.21
07.06.21
Could be worthwhile Investment >10% per year
Aravive, Inc.
Start price
Target price
Perf. (%)
€4.16
31.05.21
31.05.21
€7.00
31.05.22
31.05.22
1.44%
14.06.21
14.06.21
Could be worthwhile Investment >10% per year
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€7.24
31.05.21
31.05.21
€12.00
31.05.22
31.05.22
0.62%
14.06.21
14.06.21
Could be very worthwhile Investment >20% year
Teladoc Health Inc
Start price
Target price
Perf. (%)
€128.00
30.05.21
30.05.21
€96.00
30.05.22
30.05.22
-32.52%
20.12.21
20.12.21
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€2.86
29.05.21
29.05.21
-
29.05.22
29.05.22
-71.59%
30.05.22
30.05.22
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€125.18
28.05.21
28.05.21
€200.00
28.05.22
28.05.22
-35.69%
29.01.22
29.01.22
Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Significant cyclical dependencies